Teleflex Incorporated (TFX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 208.30 |
| Open | 208.74 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's range | 206.75 - 209.93 |
| 52-week range | 177.63 - 276.43 |
| Volume | |
| Avg. volume | 263,398 |
| Market cap | 9.768B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 27.39 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.36 (0.66%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- Zacks
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
- Simply Wall St.
Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 60% Above Its Share Price
Key Insights The projected fair value for Teleflex is US$354 based on 2 Stage Free Cash Flow to Equity Teleflex's...
- Zacks
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
© 2024 Yahoo. All rights reserved.